Study: Tea(m)Time - Strengthening the Team Resilience of Hospital Staff Through the Tea(m)Time Intervention

Study: Tea(m)Time - Strengthening the Team Resilience of Hospital Staff: A Quasi-experimental, Quantitative Pre-post Intervention Study

Employees in hospitals are exposed to various stressors and can be at risk of psychological stress. To counteract this, resilience programs are increasingly being offered. Most interventions focus on individual resilience. In this study, the focus is on the resilience of teams. For this reason, this research paper will focus on the Tea(m)Time intervention. Tea(m)Time is a health promotion intervention that combines the risk assessment of mental stress with a focus on team resilience. In order to generate knowledge about the Tea(m)Time intervention, this study aims to identify factors that promote and inhibit its implementation and mediate its effectiveness. The aim is to gain insights into the promotion of resilience in teams. The aim is to conduct the survey of the participants in the intervention group and the control group at three different points in time.

Study Overview

• Status: Recruiting
• Conditions: Resilience, Psychological; Personnel, Hospital
• Intervention / Treatment: Behavioral: Tea(m)Time

• Study Type: Interventional
• Enrollment (Estimated): 150
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Ivonne Ledtermann, MSc; Phone Number: +49 6131 289 44-185; Email: ivonne.ledtermann@kh-mz.de
• Study Contact Backup: Name: André Hennig, Diploma; Phone Number: +49 6731-50-1318; Email: a.hennig@rfk.landeskrankenhaus.de

Study Locations

• Germany
  • Bad Kreuznach, Germany, 55543
    • Recruiting
    • Klinik Viktoriastift Bad Kreuznach
    • Contact: Frank Müller; Phone Number: +496708 620-1600; Email: f.mueller@gfk.landeskrankenhaus.de
    • Contact: André Hennig; Phone Number: +496731-50-1318; Email: a.hennig@rfk.landeskrankenhaus.de
  • Bad Kreuznach, Germany, 55583
    • Active, not recruiting
    • Geriatrische Fachklinik Rheinhessen-Nahe
  • Meisenheim, Germany, 55590
    • Active, not recruiting
    • Gesundheitszentrum Glantal

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion criteria:

• be at least 18 years old
• have sufficient knowledge of German
• are not on sick leave at time t0
• work in one of the planned clinics

Exclusion criteria:

• be younger than 18 years old
• do not have sufficient knowledge of German
• are on sick leave at time t0
• do not work in one of the planned clinics

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Non-Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Control group; Receives no intervention
Experimental: Tea(m)Time; Tea(m)Time intervention: Tea(m)Time is divided into two phases, starting with the qualification of team leaders. The qualification is followed by the implementation of Tea(m)Time in the various teams.	Behavioral: Tea(m)Time; Tea(m)Time is divided into two phases, starting with the qualification of team leaders. This starts with knowledge transfer about healthy leadership, resilience, occupational health and safety, posture work, psychological empowerment, agile management and the role of the manager. The team leaders also learn various moderation/coaching techniques. The qualification is followed by the implementation of Tea(m)Time. The teams start each hour with self-reflection. This is followed by a stress assessment and prioritization. The teams then work on the problems identified and look for solutions together.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
FITOR questionnaire (questionnaire on individual, team and organizational resilience)	Schulte, E.M. et al. (2021)	t0 baseline, t1 6 months follow-up, t2 12 months follow-up

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Big-Five-Inventory-10 (BFI-10)	Rammstedt, B. et al. (2012)	t0 baseline
Psychological empowerment	Schermuly, C.C. (2019)	t0 baseline, t1 6 months follow-up, t2 12 months follow-up
Instrument to Measure the Culture for Psychological Empowerment in Organizations (IMPEC)	Schermuly, C.C. et al. (2022)	t0 baseline, t1 6 months follow-up, t2 12 months follow-up
Organizational Commitment Questionnaire (OCQ-G) German version of the Organizational Commitment Questionaire	Maier, G.W. & Woschée, R. (2014) individual items were used	t0 baseline, t1 6 months follow-up, t2 12 months follow-up
Assessment of Interprofessional Team Collaboration Scale II (AITCS-II)	Orchard C. (2015) individual items were used	t0 baseline, t1 6 months follow-up, t2 12 months follow-up
The questionnaire to record the willingness to change (FEVER)	Hasler, G. et al. (2003). Testing of the German version of the University of Rhode Island Change Assessment Scale (URICA) individual items used and adapted	t0 baseline, t1 6 months follow-up, t2 12 months follow-up
German standard version of the COPSOQ (Copenhagen Psychosocial Questionnaire)	FFAW (2023) individual items were used	t0 baseline, t1 6 months follow-up, t2 12 months follow-up

Collaborators and Investigators

• Sponsor: Catholic University of Applied Sciences Mainz
• Investigators: Principal Investigator: Nadine Ungar, Dr., Professorship for Psychology in Healthcare

Study record dates

Study Major Dates

• Study Start (Actual): March 4, 2024
• Primary Completion (Estimated): June 30, 2026
• Study Completion (Estimated): June 30, 2026

Study Registration Dates

• First Submitted: October 24, 2024
• First Submitted That Met QC Criteria: November 15, 2024
• First Posted (Actual): November 19, 2024

Study Record Updates

• Last Update Posted (Actual): March 20, 2026
• Last Update Submitted That Met QC Criteria: March 19, 2026
• Last Verified: March 1, 2026

More Information

Terms related to this study

• Other Study ID Numbers: 23-034

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No